News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MOATAZEDI DAVID
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
3
| MOATAZEDI DAVID (Director) has filed a Form 3 on BIOMERICA INC |
| 08/16/2023 |
4
| MOATAZEDI DAVID (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 91,803 shares
@ $0
Sold 14,778 shares
@ $10.27, valued at
$151.8k
|
|
| 05/09/2023 |
4
| MOATAZEDI DAVID (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 560,000 restricted stock units
@ $0 |
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2023 |
4
| MOATAZEDI DAVID (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Sold 64,211 shares
@ $8.4689, valued at
$543.8k
|
|
| 01/27/2023 |
4
| MOATAZEDI DAVID (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 187,927 shares
@ $0
Granted 257,009 options to buy
@ $11.04, valued at
$2.8M
|
|
| 05/18/2022 |
4
| MOATAZEDI DAVID (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Sold 55,321 shares
@ $13.6351, valued at
$754.3k
|
|
| 03/30/2022 |
4
| MOATAZEDI DAVID (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Sold 6,104 shares
@ $11.62, valued at
$70.9k
|
|
| 03/10/2022 |
4
| MOATAZEDI DAVID (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Sold 37,972 shares
@ $9.7254, valued at
$369.3k
|
|
| 01/26/2022 |
4
| MOATAZEDI DAVID (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 214,286 shares
@ $0
Granted 310,559 options to buy
@ $5.46, valued at
$1.7M
|
|
| 08/17/2021 |
4
| MOATAZEDI DAVID (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Sold 22,708 shares
@ $10.6602, valued at
$242.1k
Sold 47,737 shares
@ $11.3484, valued at
$541.7k
|
|
| 08/12/2021 |
4/A
| MOATAZEDI DAVID (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Sold 41,763 shares
@ $11.1783, valued at
$466.8k
|
|
| 08/12/2021 |
4
| MOATAZEDI DAVID (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Sold 41,763 shares
@ $11.1783, valued at
$466.8k
|
|
| 03/26/2021 |
4
| MOATAZEDI DAVID (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 48,853 shares
@ $0 |
|
| 02/01/2021 |
4
| MOATAZEDI DAVID (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 266,667 shares
@ $0 |
|
| 01/26/2021 |
4
| MOATAZEDI DAVID (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Sold 8,310 shares
@ $7.46, valued at
$62k
|
|
| 05/15/2020 |
4
| MOATAZEDI DAVID (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 01/24/2020 |
4
| MOATAZEDI DAVID (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 82,070 shares
@ $0
Granted 141,910 options to buy
@ $10.19, valued at
$1.4M
|
|
| 07/25/2019 |
4
| MOATAZEDI DAVID (Director) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Granted 78,125 shares
@ $0 |
|
| 01/25/2019 |
4
| MOATAZEDI DAVID (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 125,000 options to buy
@ $16.19, valued at
$2M
|
|
| 08/29/2018 |
4/A
| MOATAZEDI DAVID (Director) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Granted 81,774 options to buy
@ $2.36, valued at
$193k
|
|
| 08/27/2018 |
4
| MOATAZEDI DAVID (Director) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Granted 5,494 shares
@ $1.82, valued at
$10k
|
|
| 06/14/2018 |
4
| MOATAZEDI DAVID (Director) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Granted 81,774 options to buy
@ $2.36, valued at
$193k
|
|
| 05/08/2018 |
4
| MOATAZEDI DAVID (See Remarks) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 1,182,019 options to buy
@ $7.28, valued at
$8.6M
|
|
| 05/08/2018 |
3
| MOATAZEDI DAVID (See Remarks) has filed a Form 3 on Evolus, Inc. |
| 06/16/2017 |
4
| MOATAZEDI DAVID (Director) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Granted 36,554 options to buy
@ $9.81, valued at
$358.6k
|
|
| 03/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/15/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|